News | February 11, 2009

Live Webcast: Coronary Angioplasty with Stent Placement

February 11, 2009 – On Wednesday, Feb. 18, 2009 at 6:30 pm, Shawnee Mission Medical Center (SMMC), Merriam, KS will host an angioplasty stent placement Webcast.

Jhulan Mukharji, M.D., FACC, of Clinical Cardiovascular Associates, PA, will perform the procedure and his partner Jay Jackson, M.D., FACC, will serve as the moderator.

"This procedure has become the first choice of treatment for heart attacks when it can be performed in a timely manner," said Dr. Mukharji.

The purpose of an angioplasty stent placement procedure is to open up blockages in the blood vessels of the heart, which in the past, was done using a balloon.

"Although balloons are sometimes still used during the procedure, a stent is used in approximately 80 to 90 percent of the cases," Dr. Mukharji said. "Stents are more durable long-term in keeping the vessel open."

In appropriately selected patients, angioplasty stent placements can be done electively or emergently, are less invasive and have a shorter recovery time than bypass surgery.

Viewers can logon to the Webcast by going to ShawneeMission.org the night of the broadcasts. During the one-hour Webcast, viewers have the opportunity to submit questions to be answered live by the moderator, request more information and even make an appointment.

Source: OR-Live

For more information: www.ShawneeMission.org

Related Content

Elixir Medical Corporation Unveils Transformational DynamX Stent Featuring Adaptive Segments that Uncage the Stented Artery
News | Stents | January 25, 2018
January 25, 2018 – Elixir Medical Corporation, a leader in the development of breakthrough adaptive remodeling techno
The TIDES-ACS results show us that the Optimax stent is noninferior in patients with acute coronary syndrome compared to Synergy.

The presentation of the ESC late-breaker TIDES-ACS results show us that the Optimax stent is noninferior in patients with acute coronary syndrome compared to Synergy.

News | Stents | November 24, 2017
November 24, 2017 – During a late-breaking session at the European Society of Cardiology (ESC) 2017 meeting, presente
News | Stents | November 10, 2017
Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology portfolio, which now...
OCT comparison between the Combo vs. Xience stents in the HARMONEE study.

OCT comparison between the Combo vs. Xience stents in the HARMONEE study.

Feature | Stents | November 08, 2017
November 8, 2017 – New results from the HARMONEE Japan/U.S.
FDA Approves COBRA REDUCE Trial of 14-Day DAPT With CeloNova Stent
News | Stents | October 27, 2017
CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of CeloNova's...
CeloNova Cobra Pzf stent
Technology | Stents | March 02, 2017
March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc.
OCT, intravascular imaging, stent, good stent apposition on vessel wall, TRANSFORM-OCT study

An OCT image showing good stent strut apposition against the vessel wall.

News | Stents | January 13, 2017
January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
EXCEL Trial, TCT 2016, drug-eluting stents, CABG, surgery left main heart disease, LMCAD

Gregg W. Stone, M.D., presenting the EXCEL data at TCT 2016 during a standing room only late-breaking trial session.

Feature | Stents | January 12, 2017 | Dave Fornell
The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results
Biotronik's Osiro stent, prison IV trial

Biotronik's Osiro ultra-thin strut, sirolimus-eluting stent.

News | Stents | November 09, 2016
November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin
OCT stent strut coverage

OCT imaging showing neointimal tissue coverage of metallic stent struts.

News | Stents | November 07, 2016
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
Overlay Init